Abbott Laboratories says FDA independent panel votes to approve heart device

Abbott Laboratories said that a Food and Drug Administration panel voted in favor of the safety profile of its heart device TriClip.

Previous post Jeff Bezos unloads another $2 billion of Amazon stock. He’s sold $4 billion this month.
Next post Regional-bank stocks are back under pressure as investors get ‘a dose of reality’ about obstacles to cutting rates